Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Starting soon Not applicable

AI-Based Clinical Orientation for Nursing Students

NCT07564544 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-04-30
Last updated
2026-05-07

Condition(s) studied

OrientationClinical

Investigational drug(s) / intervention(s)

Artificial Intelligence-Based Clinical Orientation Program

Artificial Intelligence-Based Clinical Orientation Program: The program was implemented via a researcher-developed website featuring seven modules: Therapeutic Communication, Patient Safety, Medical Equipment, Infection Control, Care Plans, Ethics/Privacy, and Stress Management. AI was utilized to develop scenarios, create audiovisual materials, and simulate realistic clinical environments. Each 5-minute video used no real patient data. A sequential progression was enforced, requiring completion of one module to start the next. Knowledge was assessed after each module via 5-10 Kahoot questions. A gamified approach was used where the fastest, most accurate students earned digital badges, with the top three overall being recognized as winners. Content validity was ensured through expert opinions from pediatric nursing faculty, and necessary adjustments were made based on their feedback.

Study summary

Aim: This experimental study aims to investigate the impact of an Artificial Intelligence (AI)-based orientation program on the clinical orientation process of nursing students during their pediatric nursing clinical practice.Materials and Methods: The study population will consist of 186 third-year nursing students enrolled in the spring semester at a state university. The sample will include 90 students (45 intervention, 45 control) who meet the study criteria and volunteer to participate. Students in the intervention group will receive an AI-based clinical orientation program, while the control group will receive no additional intervention beyond the standard faculty and hospital orientation. Data will be collected between February and March 2026 using a "Descriptive Information Form," the "Clinical Adaptation Scale for Student Nurses," and the "Therapeutic Communication Skills Scale for Nursing Students" in a pre-test/post-test design.Statistical Analysis: Data will be analyzed using SPSS 25.0. Descriptive statistics (frequency, percentage, mean, and standard deviation) will be used. Normality will be assessed via Kolmogorov-Smirnov/Shapiro-Wilk tests. For group comparisons, Chi-square, ANOVA, independent samples t-test, Mann-Whitney U, and Wilcoxon tests will be utilized. The statistical significance level will be set at $p \< 0.05$.Ethical Considerations: Ethical committee approval and necessary permissions from scale authors will be obtained before the study begins. Informed consent will be collected from all participants after explaining the study objectives.Keywords: Orientation training, nursing, student, artificial intelligence, clinical practice.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Being enrolled in the Pediatric Nursing course for the first time. * Being a third-year nursing student. * Providing voluntary informed consent to participate in the study. Exclusion Criteria: * Being absent during the course of the study. * Currently being employed as a healthcare professional. * Having a frozen enrollment status.

Primary outcome measure(s)

  • Introductory Information Form — Pre-test (before the AI-supported orientation training), post-test (2 weeks after the AI-supported orientation training), and follow-up test (2 months later).
    The form was developed by the researchers in line with the relevant literature. The form consists of 3 sections and 8 questions: descriptive characteristics (age, gender, grade point average), information related to clinical adaptation (difficulty in adapting when first starting the clinical environment, difficulty in communicating with patients/families during clinical practice, and experiencing anxiety-stress before clinical practice), and information related to artificial intelligence (use of artificial intelligence programs and willingness to learn and use technological developments such as artificial intelligence).

Trial sites (2)

FacilityCityRegionStatus
Selcuk University Konya Konya
Selcuk University Konya Selçuklu
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07564544 on ClinicalTrials.gov ↗ ← All trials in Turkey